Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sheree Hazelaar"'
Autor:
Su Han Lum, Milen Minkov, Simon A. Jones, Sheree Hazelaar, Tiarlan Sirait, Jane E. Potter, Polina Stepensky, Frederic Garban, Herbert Pichler, Jerry Stein, Zuhre Kaya, Ansgar Schulz, Karin Mellgren, Cristina Diaz de Heredia, Cecile Pochon, Susana Riesco, Miguel Angel Diaz, Gérard Michel, Caroline Lindemans, Bernd Gruhn, Michael H. Albert, Arjan C. Lankester, Bénédicte Neven, Robert Wynn
Publikováno v:
Bone Marrow Transplantation. 58:594-596
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e6f14c88487f5ec096acc2daadb62c27
https://doi.org/10.1038/s41409-023-01918-4
https://doi.org/10.1038/s41409-023-01918-4
Autor:
Christian Koenecke, Dirk-Jan Eikema, Sheree Hazelaar, Thomas Schroeder, Victoria Potter, Nicolaus Kröger, Martin Bornhäuser, Jürgen Finke, Uwe Platzbecker, Aleksandar Radujkovic, Arnold Ganser, Urpu Salmenniem, Didier Blaise, Guido Kobbe, Ellen Meijer, Lone Friis, Johan Maertens, Dolores Caballero, Jan J. Cornelissen, Attilio Olivieri, Ozet Gulsum, Patrick J. Hayden, Francesco Onida, Marie Robin, Ibrahim Yakoub-Agha
Publikováno v:
Koenecke, C, Eikema, D-J, Hazelaar, S, Schroeder, T, Potter, V, Kröger, N, Bornhäuser, M, Finke, J R, Platzbecker, U, Radujkovic, A, Ganser, A, Salmenniem, U, Blaise, D, Kobbe, G, Meijer, E, Friis, L, Maertens, J, Caballero, D, Cornelissen, J J, Olivieri, A, Gulsum, O, Hayden, P J, Onida, F, Robin, M & Yakoub-Agha, I 2022, ' Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation : a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT ', Bone Marrow Transplantation, vol. 57, no. 10, pp. 1607-1611 . https://doi.org/10.1038/s41409-022-01759-7
Bone Marrow Transplantation, 57(10), 1607-1611. Nature Publishing Group
Bone Marrow Transplantation, 57(10), 1607-1611. Nature Publishing Group
ispartof: BONE MARROW TRANSPLANTATION vol:57 issue:10 pages:1607-1611 ispartof: location:England status: published
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28399940ee44b27d3c8295eb3e2bdc4d
https://lirias.kuleuven.be/handle/20.500.12942/705715
https://lirias.kuleuven.be/handle/20.500.12942/705715
Autor:
Petr Sedlacek, Susanne Matthes, Polina Stepensky, Caroline A. Lindemans, Junfeng Wang, Jolanta Gozdzik, Manfred Hoenig, Krzysztof Kałwak, Juliana F Fernandes, Su Han Lum, Brigitte Strahm, Matthias Felber, Bénédicte Neven, Arjan C. Lankester, Amal Al Seraihy, Mervi Taskinen, Ansgar Schulz, Tayfun Güngör, Franco Locatelli, Andrew R. Gennery, Mathias Hauri-Hohl, Giovanna Lucchini, Michael H. Albert, Sheree Hazelaar, Despina Moshous, Robert Wynn, Fulvio Porta, Henric Jan Blok, Brenda Gibson, Marco Zecca, Paul Veys, Fabian Hauck, Per Ljungman, Urs Schanz, Dmitry Balashov, Serap Aksoylar, Robert Chiesa, Karl Walter Sykora, Musa Karakukcu, Mary Slatter
Publikováno v:
Blood, 136(10), 1201-1211. AMER SOC HEMATOLOGY
Chronic granulomatous disease (CGD) is a primary immunodeficiency resulting in life-threatening infections and inflammatory complications. Allogeneic hematopoietic cell transplantation (allo-HCT) can cure the disease, but the indication to transplant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbc3dc7a0020fc1644f2e73747ec8ba2
http://hdl.handle.net/1887/3184828
http://hdl.handle.net/1887/3184828
Autor:
Marie Robin, Victoria Potter, Henrik Sengeloev, Guido Kobbe, Didier Blaise, Ellen Meijer, Sheree Hazelaar, Arnold Ganser, Gérard Socié, Yves Chalandon, Peter Dreger, Ibrahim Yakoub-Agha, Dietger Niederwieser, Jürgen Finke, Dirk-Jan Eikema, Francesco Onida, Johan Maertens, Hendrik Veelken, Noel Milpied, Christian Koenecke, Nicolaus Kröger, Dietrich W. Beelen, Martin Bornhaeuser, Per Ljungman, Maija Itälä-Remes
Introduction The only curative treatment approach for patients with myelodysplastic syndromes (MDS) is allogeneic hematopoietic stem cell transplantation (HSCT), but disease relapse after transplantation is a major concern. Predictors for disease out
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f6ebada494370d903c14ab5afcee817
https://doi.org/10.1112/blood-2018-99-115981
https://doi.org/10.1112/blood-2018-99-115981
Autor:
Junfeng Wang, Nicolaus Kroeger, Ibrahim Yakoub-Agha, Guillermo Garcia-Manero, Marie Robin, Pierre Fenaux, Victoria Potter, Martin Bornhäuser, Angus Broom, Francesco Onida, Vittorio Rizzoli, Raphael Itzykson, Liesbeth C. de Wreede, Jürgen Finke, Sally Killick, Mrinal M. Patnaik, Didier Blaise, Aleksandar Radujkovic, Rami S. Komrokji, Eric Solary, Sheree Hazelaar, Dietrich W. Beelen, Raajit K. Rampal, Eric Padron, Aziz Nazha
Publikováno v:
Blood. 134:4581-4581
Background: CMML is a heterogeneous disease with overlapping features of MDS and MPN. Several risk scores have been proposed in CMML, including CPSS (Such Blood 2013) that identifies 4 risk groups (low, intermediate-1 [int-1], int-2 and high risk) wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df7902ae4b7c7e70d313837d7e038425
https://doi.org/10.1182/blood-2019-125077
https://doi.org/10.1182/blood-2019-125077